BACKGROUND: Respiratory cryptosporidiosis is recognized as a late-stage complication in persons with human immunodeficiency virus (HIV) infection and AIDS. However, respiratory signs and symptoms are common in otherwise healthy children with intestinal cryptosporidiosis, which suggests that respiratory infection may occur in immunocompetent hosts. METHODS: We recruited children 9-36 months of age who presented with diarrhea to Mulago Hospital in Kampala, Uganda, from November 2007 through January 2009. Children with stool samples positive or negative for Cryptosporidium species were selected for further evaluation, including sputum induction in those with cough or unexplained respiratory signs and collection of saliva and blood specimens. Sputum samples were subjected to comprehensive bacteriologic testing, and both sputum and saliva specimens were tested for Cryptosporidium species by nested polymerase chain reaction. RESULTS: Of 926 fecal samples screened, 116 (12.5%) were positive for Cryptosporidium. Seventeen (35.4%) of 48 sputum samples tested from children with positive stool samples were positive for Cryptosporidium. Sixteen (94.1%) of the 17 children with confirmed respiratory cryptosporidiosis were HIV seronegative, and 10 (58.8%) of 17 children were not malnourished. None of the 12 sputum specimens from children with negative stool samples tested positive for Cryptosporidium (P = .013, compared with children who tested positive for Cryptosporidium in the stool). Parasite DNA was detected in only 2 (1.9%) of 103 saliva samples (P < .001, compared with sputum samples). CONCLUSIONS: Respiratory cryptosporidiosis was documented in one-third of HIV-seronegative children who were tested. These novel findings suggest the potential for respiratory transmission of cryptosporidiosis. Trial registration. ClinicalTrials.gov identifier: NCT00507871.
BACKGROUND:Respiratory cryptosporidiosis is recognized as a late-stage complication in persons with human immunodeficiency virus (HIV) infection and AIDS. However, respiratory signs and symptoms are common in otherwise healthy children with intestinal cryptosporidiosis, which suggests that respiratory infection may occur in immunocompetent hosts. METHODS: We recruited children 9-36 months of age who presented with diarrhea to Mulago Hospital in Kampala, Uganda, from November 2007 through January 2009. Children with stool samples positive or negative for Cryptosporidium species were selected for further evaluation, including sputum induction in those with cough or unexplained respiratory signs and collection of saliva and blood specimens. Sputum samples were subjected to comprehensive bacteriologic testing, and both sputum and saliva specimens were tested for Cryptosporidium species by nested polymerase chain reaction. RESULTS: Of 926 fecal samples screened, 116 (12.5%) were positive for Cryptosporidium. Seventeen (35.4%) of 48 sputum samples tested from children with positive stool samples were positive for Cryptosporidium. Sixteen (94.1%) of the 17 children with confirmed respiratory cryptosporidiosis were HIV seronegative, and 10 (58.8%) of 17 children were not malnourished. None of the 12 sputum specimens from children with negative stool samples tested positive for Cryptosporidium (P = .013, compared with children who tested positive for Cryptosporidium in the stool). Parasite DNA was detected in only 2 (1.9%) of 103 saliva samples (P < .001, compared with sputum samples). CONCLUSIONS:Respiratory cryptosporidiosis was documented in one-third of HIV-seronegative children who were tested. These novel findings suggest the potential for respiratory transmission of cryptosporidiosis. Trial registration. ClinicalTrials.gov identifier: NCT00507871.
Authors: L Xiao; C Bern; J Limor; I Sulaiman; J Roberts; W Checkley; L Cabrera; R H Gilman; A A Lal Journal: J Infect Dis Date: 2000-12-20 Impact factor: 5.226
Authors: James K Tumwine; Addy Kekitiinwa; Nicolette Nabukeera; Donna E Akiyoshi; Stephen M Rich; Giovanni Widmer; Xiaochuan Feng; Saul Tzipori Journal: Am J Trop Med Hyg Date: 2003-06 Impact factor: 2.345
Authors: Lindsay R Grant; Laura L Hammitt; David R Murdoch; Katherine L O'Brien; J Anthony Scott Journal: Clin Infect Dis Date: 2012-04 Impact factor: 9.079
Authors: Frederick S Buckner; Ranae M Ranade; J Robert Gillespie; Sayaka Shibata; Matthew A Hulverson; Zhongsheng Zhang; Wenlin Huang; Ryan Choi; Christophe L M J Verlinde; Wim G J Hol; Atsuko Ochida; Yuichiro Akao; Robert K M Choy; Wesley C Van Voorhis; Sam L M Arnold; Rajiv S Jumani; Christopher D Huston; Erkang Fan Journal: Antimicrob Agents Chemother Date: 2019-03-27 Impact factor: 5.191
Authors: George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim Journal: Pediatr Infect Dis J Date: 2013-11 Impact factor: 2.129
Authors: Lynne S Garcia; Michael Arrowood; Evelyne Kokoskin; Graeme P Paltridge; Dylan R Pillai; Gary W Procop; Norbert Ryan; Robyn Y Shimizu; Govinda Visvesvara Journal: Clin Microbiol Rev Date: 2017-11-15 Impact factor: 26.132
Authors: Daniel T Leung; Sumon K Das; M A Malek; Firdausi Qadri; A S G Faruque; Mohammod J Chisti; Edward T Ryan Journal: Am J Trop Med Hyg Date: 2015-07-06 Impact factor: 2.345
Authors: William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt Journal: Lancet Infect Dis Date: 2014-09-29 Impact factor: 25.071
Authors: Rajiv Sarkar; Sitara S R Ajjampur; Ashok D Prabakaran; Jayanthy C Geetha; Thuppal V Sowmyanarayanan; Anne Kane; Joanne Duara; Jayaprakash Muliyil; Vinohar Balraj; Elena N Naumova; Honorine Ward; Gagandeep Kang Journal: Clin Infect Dis Date: 2013-05-24 Impact factor: 9.079